Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 3 Complications of ePTFE spacer placement surgery

From: Clinical impact of spacer placement surgery with expanded polytetrafluoroethylene sheet for particle therapy

 

No. of patients (n = 131)

Intraoperative complications, n (%)

 

None

124 (94.7)

Insufficient placement of ePTFE spacer

4 (3.1)

Damage to small intestine

4 (3.1)

Acute phase complicationsa, n (%)

 

None

97 (74.0)

Surgical site infection

 

Grade 1–2

5 (3.8)

Grade 3–4

0 (0)

Ileus

 

Grade 1–2

12 (9.2)

Grade 3–4

1 (0.8)

Gastrointestinal perforation

 

Grade 1–2

0 (0)

Grade 3–4

1 (0.8)

Intestinal necrosis

 

Grade 1–2

0 (0)

Grade 3–4

1 (0.8)

Internal hernia

 

Grade 1–2

0 (0)

Grade 3–4

1 (0.8)

Ascites

 

Grade 1–2

2 (1.5)

Grade 3–4

0 (0)

Abdominal pain related to ePTFE spacer

 

Grade 1–2

9 (6.9)

Grade 3–4

0 (0)

Enteritis

 

Grade 1–2

2 (1.5)

Grade 3–4

0 (0)

Urinary tract infection

 

Grade 1–2

4 (3.1)

Grade 3–4

0 (0)

Pneumonitis

 

Grade 1–2

1 (0.8)

Grade 3–4

0 (0)

Disseminated intravascular coagulation

 

Grade 1–2

1 (0.8)

Grade 3–4

0 (0)

Late phase complicationsa, n (%)

 

None

116 (88.5)

Abscess formation

 

Grade 1–2

1 (0.8)

Grade 3–4

3 (2.3)

Gastrointestinal perforation

 

Grade 1–2

1 (0.8)

Grade 3–4

4 (3.1)

Grade 5

1 (0.8)

Refractory skin ulcer

 

Grade 1–2

0 (0)

Grade 3–4

1 (0.8)

Bladder fistula

 

Grade 1–2

0 (0)

Grade 3–4

1 (0.8)

Urinary retention

 

Grade 1–2

0 (0)

Grade 3–4

3 (2.3)

  1. ePTFE expanded polytetrafluoroethylene
  2. a Common Terminology Criteria for Adverse Events, version 5.0